- Home
- BBIO vs LLYVK Comparison
BBIO vs LLYVK Comparison
Compare BBIO & LLYVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- LLYVK
- Stock Information
- Founded
- BBIO 2015
- LLYVK 1991
- Country
- BBIO United States
- LLYVK United States
- Employees
- BBIO N/A
- LLYVK N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- LLYVK Broadcasting
- Sector
- BBIO Health Care
- LLYVK Industrials
- Exchange
- BBIO Nasdaq
- LLYVK Nasdaq
- Market Cap
- BBIO 6.7B
- LLYVK 5.9B
- IPO Year
- BBIO 2019
- LLYVK N/A
- Fundamental
- Price
- BBIO $34.57
- LLYVK $68.24
- Analyst Decision
- BBIO Strong Buy
- LLYVK
- Analyst Count
- BBIO 12
- LLYVK 0
- Target Price
- BBIO $52.64
- LLYVK N/A
- AVG Volume (30 Days)
- BBIO 2.7M
- LLYVK 680.9K
- Earning Date
- BBIO 05-01-2025
- LLYVK 01-01-0001
- Dividend Yield
- BBIO N/A
- LLYVK N/A
- EPS Growth
- BBIO N/A
- LLYVK N/A
- EPS
- BBIO N/A
- LLYVK N/A
- Revenue
- BBIO $221,902,000.00
- LLYVK N/A
- Revenue This Year
- BBIO $12.42
- LLYVK $7.29
- Revenue Next Year
- BBIO $123.19
- LLYVK N/A
- P/E Ratio
- BBIO N/A
- LLYVK N/A
- Revenue Growth
- BBIO 2285.27
- LLYVK N/A
- 52 Week Low
- BBIO $21.62
- LLYVK $33.50
- 52 Week High
- BBIO $39.47
- LLYVK $81.66
- Technical
- Relative Strength Index (RSI)
- BBIO 51.35
- LLYVK 47.65
- Support Level
- BBIO $35.77
- LLYVK $65.35
- Resistance Level
- BBIO $37.06
- LLYVK $70.85
- Average True Range (ATR)
- BBIO 1.40
- LLYVK 2.52
- MACD
- BBIO 0.18
- LLYVK 0.43
- Stochastic Oscillator
- BBIO 47.67
- LLYVK 75.79
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About LLYVK Liberty Media Corporation
Liberty Live Group would be engaged in the operations of Live Nation, and Liberty Media's planning for that group is to maximize the value of its investment in that company and the other assets attributed to the Liberty Live Group and to use the new Liberty Live common stock to make strategic acquisitions or for other capital raising initiatives.